E, Z., & B, C. (2023). Letter: Ozanimod and latent tuberculosis-authors' reply. Alimentary pharmacology & therapeutics, 57(3), 355. https://doi.org/10.1111/apt.17345
Chicago Style (17th ed.) CitationE, Zhang, and Christensen B. "Letter: Ozanimod and Latent Tuberculosis-authors' Reply." Alimentary Pharmacology & Therapeutics 57, no. 3 (2023): 355. https://doi.org/10.1111/apt.17345.
MLA (9th ed.) CitationE, Zhang, and Christensen B. "Letter: Ozanimod and Latent Tuberculosis-authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 57, no. 3, 2023, p. 355, https://doi.org/10.1111/apt.17345.
Warning: These citations may not always be 100% accurate.